Alector, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arnon Rosenthal, with a market cap of $264.9M.
Common questions about Alector, Inc.
Alector, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $7.8M.
Alector, Inc. has approximately 244 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.